Intricatinol synergistically enhances the anticancerous activity of cisplatin in human A549 cells via p38 MAPK/p53 signalling
|
journal
|
July 2017 |
Recent advances with liposomes as pharmaceutical carriers
|
journal
|
February 2005 |
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
|
journal
|
February 2013 |
Ultraviolet light-mediated drug delivery: Principles, applications, and challenges
|
journal
|
December 2015 |
Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania
|
journal
|
June 2010 |
Surgery of primary sites for stage IVB cervical cancer patients receiving chemoradiotherapy: a population-based study
|
journal
|
January 2020 |
Betulinic acid suppresses breast cancer aerobic glycolysis via caveolin-1/NF-κB/c-Myc pathway
|
journal
|
March 2019 |
Inhibition effect of Guizhi-Fuling-decoction on the invasion of human cervical cancer
|
journal
|
October 2008 |
A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment
|
journal
|
June 2021 |
Can nanomaterials support the diagnosis and treatment of human infertility? A preliminary review
|
journal
|
June 2022 |
Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model
|
journal
|
February 2012 |
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
|
journal
|
December 2012 |
Cancer drug delivery in the nano era: An overview and perspectives
|
journal
|
February 2017 |
Ultrasound-assisted preparation of different nanocarriers loaded with food bioactive ingredients
|
journal
|
August 2019 |
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
|
journal
|
June 2019 |
Statistical Modeling of the Drug Load Distribution on Trastuzumab Emtansine (Kadcyla), a Lysine-Linked Antibody Drug Conjugate
|
journal
|
June 2014 |
CoNiZn and CoNiFe Nanoparticles: Synthesis, Physical Characterization, and In Vitro Cytotoxicity Evaluations
|
journal
|
June 2021 |
Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions
|
journal
|
March 2009 |
Enhanced therapeutic efficacy of Piperlongumine for cancer treatment using nano-liposomes mediated delivery
|
journal
|
August 2023 |
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems
|
journal
|
January 2014 |
Functionalized niosomes as a smart delivery device in cancer and fungal infection
|
journal
|
January 2022 |
Theranostic nanomedicine: Potential therapeutic epitome
|
journal
|
January 2015 |
Development and classification of RNA aptamers for therapeutic purposes: an updated review with emphasis on cancer
|
journal
|
November 2022 |
Nano magnetic liposomes-encapsulated parthenolide and glucose oxidase for ultra-efficient synergistic antitumor therapy
|
journal
|
June 2020 |
EGCG Nanoparticles Attenuate Aluminum Chloride Induced Neurobehavioral Deficits, Beta Amyloid and Tau Pathology in a Rat Model of Alzheimer’s Disease
|
journal
|
August 2018 |
Global strategies for cervical cancer prevention and screening
|
journal
|
July 2019 |
Liposome: classification, preparation, and applications
|
journal
|
February 2013 |
Following nanomedicine activation with magnetic resonance imaging: why, how, and what’s next?
|
journal
|
August 2019 |
Withaferin A inhibits proliferation of human endometrial cancer cells via transforming growth factor-β (TGF-β) signalling
|
journal
|
June 2021 |
Ursolic acid liposomes with chitosan modification: Promising antitumor drug delivery and efficacy
|
journal
|
February 2017 |
Dietary flavonoids, luteolin and quercetin, inhibit invasion of cervical cancer by reduction of UBE2S through epithelial–mesenchymal transition signaling
|
journal
|
January 2017 |
Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs
|
journal
|
May 2022 |
Betaine Effects on Morphology, Proliferation, and p53-induced Apoptosis of HeLa Cervical Carcinoma Cells in Vitro
|
journal
|
April 2015 |
Fabrication of a pH responsive DOX conjugated PEGylated palladium nanoparticle mediated drug delivery system: an in vitro and in vivo evaluation
|
journal
|
January 2015 |
Indole-3-Carbinol and Diindolylmethane Induce Apoptosis of Human Cervical Cancer Cells and in Murine HPV16-Transgenic Preneoplastic Cervical Epithelium
|
journal
|
December 2001 |
Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma
|
journal
|
August 2009 |
Selection of Treatment Regimens for Recurrent Cervical Cancer
|
journal
|
February 2021 |
Advanced in developmental organic and inorganic nanomaterial: a review
|
journal
|
January 2020 |
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)
|
journal
|
April 2020 |
The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer
|
journal
|
October 2004 |
Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells
|
journal
|
October 2013 |
Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systems
|
journal
|
January 2022 |
A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers
|
journal
|
August 2016 |
Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo
|
journal
|
March 2009 |
Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest
|
journal
|
October 2015 |
The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia
|
journal
|
June 2005 |
Caffeic Acid Induces Apoptosis in Human Cervical Cancer Cells Through the Mitochondrial Pathway
|
journal
|
December 2010 |
An Updated Review on Implications of Autophagy and Apoptosis in Tumorigenesis: Possible Alterations in Autophagy through Engineered Nanomaterials and Their Importance in Cancer Therapy
|
journal
|
May 2021 |
Cancer statistics, 2019
|
journal
|
October 2018 |
Targeting immunoliposomes to EGFR-positive glioblastoma
|
journal
|
February 2022 |
Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitiors of matrix metalloproteinase-1 expression
|
journal
|
December 2012 |
Stability of blueberry anthocyanin, anthocyanidin and pyranoanthocyanidin pigments and their inhibitory effects and mechanisms in human cervical cancer HeLa cells
|
journal
|
January 2019 |
Molecular mechanisms of cisplatin resistance in cervical cancer
|
journal
|
June 2016 |
Human papilloma virus 16 e6 protein as a target for curcuminoids, curcumin conjugates and congeners for chemoprevention of oral and cervical cancers
|
journal
|
June 2013 |
PLGA Nanoparticle-Based Formulations to Cross the Blood–Brain Barrier for Drug Delivery: From R&D to cGMP
|
journal
|
April 2021 |
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
|
journal
|
September 2010 |
Cancer chemoprevention with dietary phytochemicals
|
journal
|
December 2003 |
Controlled drug delivery vehicles for cancer treatment and their performance
|
journal
|
March 2018 |
Cellular and molecular mechanisms of silibinin induces cell-cycle arrest and apoptosis on HeLa cells
|
journal
|
December 2011 |
A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
|
journal
|
June 2014 |
Natural carbon-based quantum dots and their applications in drug delivery: A review
|
journal
|
December 2020 |
Sesamin induces ER stress-mediated apoptosis and activates autophagy in cervical cancer cells
|
journal
|
May 2018 |
Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans
|
journal
|
April 2012 |
Folic Acid-Adorned Curcumin-Loaded Iron Oxide Nanoparticles for Cervical Cancer
|
journal
|
February 2022 |
Chemotherapy and targeted therapy in the management of cervical cancer
|
journal
|
March 2018 |
Derivative of Epigallocatechin-3-gallatea Encapsulated in ZIF-8 with Polyethylene Glycol–Folic Acid Modification for Target and pH-Responsive Drug Release in Anticancer Research
|
journal
|
November 2018 |
Cancer Chemoprevention by Dietary Phytochemicals: Promises and Pitfalls
|
journal
|
January 2012 |
Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours
|
journal
|
November 2017 |
Betulinic Acid Suppresses Breast Cancer Metastasis by Targeting GRP78-Mediated Glycolysis and ER Stress Apoptotic Pathway
|
journal
|
August 2019 |
The Involvement of Natural Polyphenols in the Chemoprevention of Cervical Cancer
|
journal
|
August 2021 |
Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC)
|
journal
|
November 2017 |
Radiation therapy‐associated toxicity: Etiology, management, and prevention
|
journal
|
July 2021 |
Baicalin loaded in folate-PEG modified liposomes for enhanced stability and tumor targeting
|
journal
|
April 2016 |
PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression
|
journal
|
June 2022 |
Folic acid-poly(N-isopropylacrylamide-maltodextrin) nanohydrogels as novel thermo-/pH-responsive polymer for resveratrol breast cancer targeted therapy
|
journal
|
January 2023 |
Cancer of the cervix uteri: 2021 update
|
journal
|
October 2021 |
The anticancer effects of ferulic acid is associated with induction of cell cycle arrest and autophagy in cervical cancer cells
|
journal
|
July 2018 |
Preparation of Paclitaxel-Encapsulated Bio-Functionalized Selenium Nanoparticles and Evaluation of Their Efficacy against Cervical Cancer
|
journal
|
October 2022 |
Cervical cancer therapies: Current challenges and future perspectives
|
journal
|
June 2022 |
The Need for Improvement of the Treatment of Advanced and Metastatic Cervical Cancer, the Rationale for Combined Chemo-Immunotherapy
|
journal
|
January 2014 |
Liposomal curcumin and its application in cancer
|
journal
|
August 2017 |
Potential of nano-phytochemicals in cervical cancer therapy
|
journal
|
June 2020 |
Evolution in Fertility-Preserving Options for Early-Stage Cervical Cancer
|
journal
|
July 2013 |
Validation of a Strategy for Cancer Therapy: Delivering Aminoglycoside Drugs to Mitochondria in HeLa Cells
|
journal
|
February 2016 |
Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects
|
journal
|
September 2015 |
Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma
|
journal
|
July 2017 |
Principles of nanoparticle design for overcoming biological barriers to drug delivery
|
journal
|
September 2015 |
Naringin induces death receptor and mitochondria-mediated apoptosis in human cervical cancer (SiHa) cells
|
journal
|
January 2013 |
Silymarin Inhibits Cervical Cancer Cell Through an Increase of Phosphatase and Tensin Homolog
|
journal
|
October 2011 |
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
|
journal
|
March 2009 |
Nanoparticle-based targeted drug delivery
|
journal
|
June 2009 |
Phytochemicals in Gynecological Cancer Prevention
|
journal
|
January 2021 |
Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans
|
journal
|
January 2015 |
Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4‐ATF3‐CHOP axis
|
journal
|
October 2019 |
Mifamurtide
|
journal
|
June 2010 |
Equivalency challenge: Evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model
|
journal
|
May 2016 |
Possible role of nanocarriers in drug delivery against cervical cancer
|
journal
|
January 2017 |
Single Agent Versus Combination Chemotherapy in Recurrent Cervical Cancer
|
journal
|
December 1998 |
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
|
journal
|
February 2016 |
Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors
|
journal
|
August 2021 |
Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial
|
journal
|
August 2018 |
Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy
|
journal
|
March 2021 |
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study
|
journal
|
October 2018 |
Soft Cationic Nanoparticles for Drug Delivery: Production and Cytotoxicity of Solid Lipid Nanoparticles (SLNs)
|
journal
|
October 2019 |
Furin-responsive triterpenine-based liposomal complex enhances anticervical cancer therapy through size modulation
|
journal
|
January 2020 |
Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/AKT and telomerase pathways
|
journal
|
May 2017 |
A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems
|
journal
|
January 2020 |
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
|
journal
|
April 2012 |
The mechanism of kaempferol induced apoptosis and inhibited proliferation in human cervical cancer SiHa cell: From macro to nano
|
journal
|
February 2016 |
A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix
|
journal
|
March 2015 |
Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
|
journal
|
March 2015 |
Pegylated liposomal doxorubicin (Lipo-Dox®) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-up
|
journal
|
June 2006 |
Active targeting liposome-PLGA composite for cisplatin delivery against cervical cancer
|
journal
|
December 2020 |
Efficacy and tolerability of 1- and 3-month leuprorelin acetate depot formulations (Eligard ® /Depo-Eligard ® ) for advanced prostate cancer in daily practice: a Belgian prospective non-interventional study
|
journal
|
January 2014 |
Intensified Systemic Therapy Regimens in Combination With Definitive Radiation for Treatment of Cervical Cancer
|
journal
|
October 2020 |
Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy
|
journal
|
July 2019 |
Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer
|
journal
|
December 2005 |
Cyanidin‐3‐ O ‐glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells
|
journal
|
April 2021 |
Stimuli-responsive Carriers for Controlled Intracellular Drug Release
|
journal
|
July 2019 |
Hollow Magnetic Nanoparticles: Synthesis and Applications in Biomedicine
|
journal
|
April 2012 |
Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy
|
journal
|
November 2013 |
Plants and cervical cancer: an overview
|
journal
|
June 2013 |
Sulforaphane, a Dietary Isothiocyanate, Induces G2/M Arrest in Cervical Cancer Cells through CyclinB1 Downregulation and GADD45β/CDC2 Association
|
journal
|
September 2016 |
Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnology
|
journal
|
August 2019 |
Carbon Nanotubes: Current Perspectives on Diverse Applications in Targeted Drug Delivery and Therapies
|
journal
|
November 2021 |
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
|
journal
|
February 2021 |
Inhibition of Cervical Cancer by Promoting IGFBP7 Expression Using Ellagic Acid from Pomegranate Peel
|
journal
|
December 2016 |
Recurrent cervical cancer treated with palliative chemotherapy: real-world outcome
|
journal
|
October 2020 |
Nanocarriers for cancer-targeted drug delivery
|
journal
|
June 2015 |
Recent Applications of Magnetically Recoverable Nanocatalysts in CC and CX Coupling Reactions
|
journal
|
June 2015 |
Pegasparaginase: where do we stand?
|
journal
|
November 2008 |
Phospholipid prodrug conjugates of insoluble chemotherapeutic agents for ultrasound targeted drug delivery
|
journal
|
January 2020 |
Cervical Cancer: An Overview of Pathophysiology and Management
|
journal
|
April 2019 |
Immunizing against Anogenital Cancer: HPV Vaccines
|
journal
|
May 2016 |
Phytochemicals based chemopreventive and chemotherapeutic strategies and modern technologies to overcome limitations for better clinical applications
|
journal
|
September 2019 |
Correction to: New insights into the application of nanoghosts as theranostic tools with an emphasis on cardiovascular diseases
|
journal
|
September 2022 |
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
|
journal
|
April 2013 |
Targeted Drug Delivery — From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives
|
journal
|
July 2021 |
Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications
|
journal
|
December 2017 |
Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer
|
journal
|
October 2020 |
Phytochemicals: Potential Lead Molecules for MDR Reversal
|
journal
|
June 2020 |
Oxidative Stress Triggered by Apigenin Induces Apoptosis in a Comprehensive Panel of Human Cervical Cancer-Derived Cell Lines
|
journal
|
January 2017 |
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
|
journal
|
August 2012 |
Cancer cell-specific photoactivity of pheophorbide a–glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice
|
journal
|
September 2013 |
Doxil® — The first FDA-approved nano-drug: Lessons learned
|
journal
|
June 2012 |
Selective Prostate Cancer Thermal Ablation With Laser Activated Gold Nanoshells
|
journal
|
February 2008 |
Liposomal vincristine in relapsed non-Hodgkin's lymphomas: Early results of an ongoing phase II trial
|
journal
|
January 2000 |
Nanotechnology for Therapy of Zoonotic Diseases: A Comprehensive Overview
|
journal
|
June 2022 |
Preparation of curcumin-poly (allyl amine) hydrochloride based nanocapsules: Piperine in nanocapsules accelerates encapsulation and release of curcumin and effectiveness against colon cancer cells
|
journal
|
April 2020 |
New Pharmacological Opportunities for Betulinic Acid
|
journal
|
December 2017 |
Thermosensitive liposomes for localized delivery and triggered release of chemotherapy
|
journal
|
July 2013 |
Liposome technology and the development of Myocet™ (liposomal doxorubicin citrate)
|
journal
|
June 2001 |
Nanocarriers as an emerging platform for cancer therapy
|
journal
|
December 2007 |
Cervical Cancer: 2018 Revised International Federation of Gynecology and Obstetrics Staging System and the Role of Imaging
|
journal
|
May 2020 |
Paris saponin VII suppressed the growth of human cervical cancer Hela cells
|
journal
|
August 2014 |
Human papillomavirus and cervical cancer
|
journal
|
September 2013 |
Gallic Acid Enhancement of Gold Nanoparticle Anticancer Activity in Cervical Cancer Cells
|
journal
|
February 2015 |
New Developments in Liposomal Drug Delivery
|
journal
|
April 2015 |
A Phase I Study of Hepatic Arterial Infusion Chemotherapy with Zinostatin Stimalamer Alone for Hepatocellular Carcinoma
|
journal
|
November 2003 |
Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)
|
journal
|
August 2009 |